Eds: This story was supplied by The Conversation for AP customers. The Associated Press does not guarantee the content.

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.

The Steelworkers Humanity Fund (SHF) is donating $20,000 to support people and communities evacuated due to the recent wildfires in Manitoba.

PDS Biotechnology Corporation (NASDAQ:PDSB) unveiled compelling new data on its Versamune HPV (PDS0101) immunotherapy at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

In a letter sent to Alberta’s pharmacists, Health Minister Adriana LaGrange goes on about how much she values the work they do. LaGrange indicates that pharmacies are highly valued in Alberta ...

Your trusted source for the latest news delivered weekdays from the team at U.S. News and World Report. Sign in to manage your newsletters » Sign up to receive the latest updates from U.S. News ...

As guest countries of honor, Slovakia and Slovenia presented smart mobility and green technology projects, highlighting ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

Hyperspectral reporters allow bacteria on the ground to be imaged by high-flying drones, expanding environmental monitoring to large outdoor areas. Producing goods, such as foods and fuels, with ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Photo Caption: CloudTen Residential recently took over management of OneR MidTown in Reno. Following many… Artist - Nick Maltagliati The power of a great collection lies in the caliber of the ...

DOVER, Del., April 28, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company today reports confirmatory preclinical efficacy data for PORT-7 (TT-4 ...